Anabelle de la Barra

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · The Lancet Infectious Diseases · 2018 · 297 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

Faustino Torrico, Joaquím Gascón, Fabiana Barreira et al. · The Lancet Infectious Diseases · 2021 · 199 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease

Rudy Parrado, Juan Carlos Ramı́rez, Anabelle de la Barra et al. · Antimicrobial Agents and Chemotherapy · 2018 · 51 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +17

First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease

Rudy Parrado, Elena Sulleiro, Anabelle de la Barra et al. · PLoS ONE · 2017 · 31 citations · Full text

Veterinary Medicine, Infectious Diseases, Diagnostic Parasitology +16